On May 15, 2015, Partner Sheila Swaroop authored “Boundaries of BPCIA Patent Exchange Get Tested in Court” featured in The Recorder. The article discussed an overview of the BPCIA Patent Exchange, patent litigation between Amgen and Sandoz, and the Celltrion/Hospira litigation. The recent and ongoing litigation over the BPCIA provide some initial insights into how the BPCIA will govern future patent disputes over biosimilar applications.
Read the full article here. (Subscription Required)
